{"id":898952,"title":"Chapter 4: Cancer incidence in Canada: trends and projections (1983-2032) – Melanoma - HPCDP: Volume 35, Supplement 1, Spring 2015 - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-08","captureTimestamp":"2026-03-08T11:47:38.187000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-35-no-1-2015/supplement/page-25.html","snippet":"Chapter 4: Cancer incidence in Canada: trends and projections (1983-2032) – Melanoma - HPCDP: Volume 35, Supplement 1, Spring 2015 Previous page Table of Contents Next page Chapter 4: Projections by Cancer Site 9. Melanoma Cutaneous malignant melanoma (referred to as melanoma) is…","rawSnapshotUrl":"/api/snapshots/raw/898952","browseUrl":"https://replay.healtharchive.ca/job-7/20260308114738/https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-35-no-1-2015/supplement/page-25.html#ha_snapshot=898952","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}